Riskpilot← Back to searchSign inGet full accessHYPEX BIO NORGE AS
ASActiveOrg 927168103Tylldalsveien 141, 2500 TynsetWholesale of chemical products · NACE 4685Est. 20215 employees
Revenue 2024
NOK 8,3M
+44% vs 2023
EBITDA margin
-46.6%
-73% vs 2023
Equity ratio
-22.5%
Financial strength
Net profit 2024
NOK -5,9M
-90% vs 2023
| Revenue | NOK 8,3M | +44% |
| EBITDA | NOK -3,9M | -73% |
| Net profit | NOK -5,9M | -90% |
| Total assets | NOK 22,7M | +17% |
| Equity | NOK -5,1M | -763% |
| Employees | 5 | — |
Legal name
HYPEX BIO NORGE AS
Org number
927168103
Legal form
Aksjeselskap
NACE code
4685 · Wholesale of chemical products
Founded
11. juni 2021
Share capital
NOK 110 389
Employees
5 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene. Daglig leder alene.
Company purpose
Drive produksjon, utvikling og handel med eksplosiver og kjemiske råvarer samt mekanisk utstyr og utføre operasjoner som er kompatible med dette.
Address
Tylldalsveien 141, 2500 Tynset
Email
info@hypexbio.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Revenue | 0 | 1 507 | 5 774 | 8 312 |
| Staff expenses | −0 | −1 153 | −3 686 | −4 491 |
| EBITDA | −226 | −2 211 | −2 234 | −3 873 |
| Depreciation & amort. | −0 | −9 | −1 768 | −3 129 |
| EBIT | −226 | −2 219 | −4 003 | −7 002 |
| Net financials | 0 | 16 | −371 | −1 217 |
| Profit before tax | −226 | −2 204 | −4 374 | −8 219 |
| Tax | −0 | −536 | −1 278 | −2 350 |
| Net profit | −226 | −1 668 | −3 096 | −5 869 |
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Total assets | 127 | 5 209 | 19 422 | 22 687 |
| Equity | −202 | 2 684 | 769 | −5 100 |
| Long-term debt | 300 | 1 750 | 11 355 | 8 426 |
| Short-term debt | 29 | 775 | 7 298 | 19 361 |
| Total debt | 329 | 2 525 | 18 653 | 27 787 |
EBITDA margin
-46.6%
This company
15.8%
Market median
-395% vs market
20212024
Equity ratio
-22.5%
This company
38.2%
Market median
-159% vs market
20212024
Return on equity
-586907800.0%
This company
18.4%
Market median
-3189716404% vs market
20212024
Net profit margin
-70.6%
This company
8.1%
Market median
-972% vs market
20212024
Asset turnover
0.37×
This company
1.12×
Market median
-67% vs market
20212024
Debt / equity
5.45×
This company
0.62×
Market median
-779% vs market
20212024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-05-03 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
TN Chief Executive Officer | Chief Executive Officer | 2021 |
| Name | Role | Member since |
|---|---|---|
| Current (6) | ||
| Board of Directors | 2021 | |
| Chairman | 2025 | |
| Board of Directors | 2021 | |
| Chairman | 2021 | |
| Board of Directors | 2023 | |
| Board of Directors | 2023 | |
| Former (1) | ||
| Board of Directors | 2021 – 2023 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 92.47% | 92.47% | 2024 | |
Hypex Bio Explosives Technology Ab | Company | 7.53% | 7.53% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of HYPEX BIO NORGE AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Tron Nytrøen | Chief Executive Officer | 0 companies |
| Vegard Strandvik | Board of Directors | 0 companies |
| Øivind Motrøen | Chairman | 0 companies |
| Timothy Shawe Hunt | Board of Directors | 0 companies |
| Hanne Markussen Eek | Chairman | 0 companies |
| Torbjørn Byvold | Board of Directors | 0 companies |
| Jørn Randmæl Nesseth | Board of Directors | 0 companies |
| Ove Robert Bertil Håkland | Board of Directors | 0 companies |